| Vol. 10.10 – 18 March, 2021 |
| |
|
|
| Researchers used direct RNA sequencing to analyze transcript expression from the ChAdOx1 nCoV-19 genome in human MRC-5 and A549 cell lines that were non-permissive for vector replication alongside the replication permissive cell line, HEK293. They also used quantitative proteomics to study over time the proteome and phosphoproteome of A549 and MRC5 cells infected with the ChAdOx1 nCoV-19 vaccine. [Genome Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Using a phospho-receptor tyrosine kinase (RTK) array screen, investigators identified the RTK, AXL, as a top upregulated RTK in response to smoke. Both expression and signaling activity of AXL were elevated in lung fibroblasts exposed to tobacco-smoke, whereas no significant change to the levels of a canonical AXL ligand, growth arrest-specific 6, was seen upon smoke treatment. [American Journal of Respiratory Cell and Molecular Biology] |
|
|
|
| Scientists generated alveolar organoids derived from human pluripotent stem cells for use as an pulmonary fibrosis model and for drug efficacy evaluation. [Cell Death Discovery] |
|
|
|
| Investigators loaded hybrid core–shell nanoparticles (hNPs) with a 7-mer peptide nucleic acid (PNA) previously considered for its ability to modulate the post-transcriptional regulation of the CF transmembrane conductance regulator gene. They also investigated the in vitro release kinetics of hNPs and their efficacy in PNA delivery across the human epithelial airway barrier using an ex vivo model based on human primary nasal epithelial cells from CF patients. [Scientific Reports] |
|
|
|
| To examine the potential toxicological effects of microplastics on human cells, the cultured human alveolar A549 cells were exposed to polystyrene microplastics of one and ten μm diameter as a model of the environmental contaminants. [Chemical Research in Toxicology] |
| |
|
|
| The authors investigated a regulatory network underlying phenotypic heterogeneity in SCLC, a devastating disease with no molecular targeted therapy. [eLife] |
|
|
|
| MSI2 control of EGFR expression and activity in an NSCLC cell line panel was studied using RT-PCR, Western blots, and RNA immunoprecipitation. Functional consequences of MSI2 depletion were explored for cell growth and response to EGFR-targeting drugs, in vitro and in vivo. [Oncogenesis] |
|
|
|
| Scientists revealed that apigenin directed alternative splicing and inhibited heat shock protein 70 enhancing tumor necrosis factor-related apoptosis-inducing ligand anticancer activity. [Cell Death & Disease] |
|
|
|
| Researchers evaluated the antiproliferative ability of punicalagin against lung cancer A549 cells by inducing apoptosis through inhibiting STAT‐3 activation. [Oncogenesis] |
|
|
|
|
| The authors provide a broad overview of the roles of extracellular vesicles (EV) in chronic respiratory disease. Recent advances in profiling EVs have shown their potential as biomarker candidates. Studies have provided insight into their disease pathology, particularly in inflammatory processes across a spectrum of lung diseases. [Thorax] |
|
|
|
| Scientists discuss some uncommon alterations in NSCLC such as ROS1, BRAF, RET, HER2, NTRK, MET and other targets that are in an early evaluation phase. They also summarize the characteristics of patients harboring these alterations, the already approved or under investigation therapies and the related resistance mechanisms. [Critical Reviews in Oncology/Hematology] |
|
|
|
|
| Indivumed GmbH announced the founding of Ix Therapeutics GmbH, a joint venture with Xlife Sciences AG, which marks Indivumed’s expansion into target discovery and early cancer drug development. Initially, Ix Therapeutics will work with Veraxa Biotech AG to utilize their technology for rapid development of functional therapeutic antibodies, first focusing on colon and lung cancer. [Indivumed GmbH] |
|
|
|
|
| April 19 – 23, 2021 Virtual |
|
|
|
|
|
| Translate Bio – Lexington, Massachusetts, United States |
|
|
|
| United Therapeutics Corporation – Manchester, New Hampshire, United States |
|
|
|
| Translate Bio – Lexington, Massachusetts, United States |
|
|
|
| Brigham and Woman’s Hospital – Boston, Massachusetts, United States |
|
|
|
| Translate Bio – Lexington, Massachusetts, United States |
|
|
|
|